Newsletter «Science & innovation» N°17 - Summer 2026 edition
Oncology is entering a new era, in which progress increasingly depends on the ability to combine scientific innovation, clinical expertise and institutional collaboration. From immunotherapy to personalised vaccines, via translational research, the wellbeing of healthcare professionals and artificial intelligence, the future of cancer care will also depend on our ability to integrate these different dimensions into coherent, patient-centred strategies.
This newsletter, dedicated to oncology strategies, reflects this dynamic vision and highlights several initiatives and insights at the crossroads of research, clinical practice and innovation.
In this issue, Tiia Snäka, from the Clinical and Translational Unit at Swiss Medical Network, in collaboration with her colleagues, highlights a major turning point in research into cancer vaccines: their true clinical value lies in combined strategies rather than in their use in isolation. By aligning vaccination with optimal immunological windows and integrating it with standard treatments, this approach opens up new prospects for achieving more durable and effective anti-tumour responses in solid tumours.
During his second visit to the Clinique de Genolier, Professor Roberto Orecchia helped to strengthen the strategic partnership between Swiss Medical Network and the European Institute of Oncology in Milan, with a focus on clinical research, translational oncology, personalised vaccines, radio-oncology and theranostics. In this newsletter, we look back at this meeting, which aimed to identify concrete opportunities for joint clinical trials and R&D projects, whilst strengthening coordination between the Clinical and Translational Research Unit, the Genolier Innovation Hub and the oncology teams involved in this partnership.
Burnout in oncology is not merely a matter of individual fatigue: it can affect the quality of care, job satisfaction and staff retention. In a recent article published in JCO Oncology Practice, Alexandru Eniu highlights the role of imposter syndrome and perfectionism in the exhaustion of oncology professionals. He thus emphasises the need to address both the working environment and the psychological factors that make healthcare professionals vulnerable.
Finally, this newsletter highlights a major advance in modern oncology: theranostics, which combines cancer diagnosis and targeted treatment within a single molecular approach. This innovation will soon be available at the Clinique de Genolier, led by Dr Antoine Leimgruber and the nuclear medicine team at Swiss Theranostics, who will support patients through this new approach, which is more precise and better tailored to each individual’s situation.
